Genes associated with immune response are upregulated in clinically healthy skin of patients with gliptin-associated bullous pemphigoid

    Nina Kokkonen, Outi Varpuluoma, Jussi Tuusa, Katri Pylkäs, Laura Huilaja, Kaisa Tasanen

    Journal of Investigative Dermatology (2026)

    Published on October 21, 2026

    DOI: https://doi.org/10.1016/j.jid.2026.01.035

    Core: Finnish Functional Genomics Centre
    ← Back to Publications

    Most recent publications from our users

    User Publication
    Genes associated with immune response are upregulated in clinically healthy skin of patients with gliptin-associated bullous pemphigoid
    N. Kokkonen et al. • 2026 • Journal of Investigative Dermatology
    Core:Finnish Functional Genomics Centre
    User Publication
    Improving genotyped functional screening: A versatile closed-tube PCR for Illumina library generation reduces background sequences in multiplexed sequencing
    S. Oksanen et al. • 2026 • SLAS Technology
    Core:Finnish Functional Genomics Centre
    User Publication
    Dynamic landscape of transcription initiation by yeast RNA polymerase I
    O. Parilova et al. • 2026 • Nucleic Acids Research
    Core:Protein Structure and Chemistry
    User Publication
    <i>Staphylococcus aureus</i> Augments Epithelial Skin Barrier Damage Through T Cell Activation in Cutaneous T Cell Lymphoma
    M. Gluud et al. • 2026 • Allergy
    Core:Cytometry Core
    User Publication
    Fast label-free live imaging with FlowVision reveals key principles of cancer cell arrest on endothelial monolayers
    G. Follain et al. • 2026 • The EMBO Journal
    Core:Advanced Imaging Core

    More User Publications

    User Publication
    December 2, 2025
    High-throughput cell-based screening of 4910 known drugs and drug-like small molecules identifies disulfiram as an inhibitor of prostate cancer cell growth
    Iljin K, Ketola K, Vainio P, Halonen P, Kohonen P, Fey V, Grafström RC, Perälä M, Kallioniemi O Clinical Cancer Research (2009)
    Abstract Purpose: To identify novel therapeutic opportunities for patients with prostate cancer, we applied high-throughput screening to systematically explore most...
    Read abstract